当前位置:
Anti-Human HLA-DQ – Purified In vivo GOLD Functional Grade,H262

Anti-Human HLA-DQ – Purified In vivo GOLD Functional Grade,H262

0.00
0.00
  
商品描述
Anti-Human HLA-DQ – Purified In vivo GOLD Functional Grade,H262,leinco

Clone: 1a3

Product Type: Monoclonal Antibody
Alternate Names: HLA-DQ Monomorphic
Isotype:
Mouse
IgG2a 






Prod No.
Size
Price
Avail.
Qty
Add to cart
H262-1.0 mg
1.0 mg
$95.00
In stock
Add to Cart
H262-5.0 mg
5.0 mg
$298.00
In stock
Add to Cart
H262-25 mg
25 mg
$775.00
In stock
Add to Cart
H262-50 mg
50 mg
$1,275.00
In stock
Add to Cart
H262-100 mg
100 mg
$1,998.00
In stock
Add to Cart

Antibody Details

Matched Isotype Control
Mouse IgG2a Isotype Control – Purified Functional Grade, GOLD
Reactivity Species
Human
Host Species
Mouse
Immunogen
Unknown
Product Concentration
1.0 mg/ml
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
RRID
AB_LEINCO
Specificity
Anti-HLA-DQ (clone 1a3) recognizes a monomorphic epitope present on HLA-DQ molecules of the human class II major histocompatibility complex (MHC). Anti-HLA-DQ does not react with HLA-DR or HLA-DP molecules.
Antigen Distribution
The HLA-DQ antigen is present on approximately 10% of peripheral blood lymphocytes. This antibody reacts with virtually all B-cell lines and some tissue macrophages and dendritic cells.

Antigen Details

Protein Family
HLA-DQ
Ligand/Receptor
CD3/TCR, CD4

References & Citations

1. Bellone, CJ. et al. (1996) J Clin Invest. 97(10):2324-31. PubMed
2. Ikeda Y. et al. (2003) Blood.101(2):621-3. Article Link
3. Wright, TM et al. (2000) J Immunol.164(12):6138-46.PubMed
4. Wright, TM et al. (2001) Arthritis Rheum. 44(7):1654-9. PubMed
5. Nishikawa, Takeji et al. (2000) Journal of Investigative Dermatology 114(1): 88-94. PubMed
6. Shookster et al. (1987) Human Immunol. 20:59

Technical Protocols

Flow Cytometry
General Western Blot Protocol